Guangyuan Lou

Salvage treatment with apatinib for advanced non-small-cell lung cancer

Zhengbo Song, Xinmin Yu, Guangyuan Lou et al. · OncoTargets and Therapy · 2017 · 60 citations · Full text

Medicine, Oncology, Pharmacology +17

The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study

Wenxian Wang, Xiaodong Gu, Liping Wang et al. · Cancer Immunology Immunotherapy · 2021 · 50 citations · Full text

Life Sciences, Immunology, Oncology +17

Immune checkpoint inhibitor‐related adverse events in lung cancer: Real‐world incidence and management practices of 1905 patients in <scp>China</scp>

Yuequan Shi, Jian Fang, Chengzhi Zhou et al. · Thoracic Cancer · 2021 · 40 citations · Full text

Medicine, Oncology, Pharmacology +17

Boundary element analysis of packed silencers with a substructuring technique

Guangyuan Lou, Ting Wu, C.Y.R. Cheng · Engineering Analysis with Boundary Elements · 2003 · 38 citations

Natural Sciences, Electrical Engineering, Physics +7

Mutational profiling of non-small-cell lung cancer patients resistant to first-generation EGFR tyrosine kinase inhibitors using next generation sequencing

Ying Jin, Yang Shao, Xun Shi et al. · Oncotarget · 2016 · 38 citations · Full text

Medicine, Molecular Genetics, Oncology +17